Drug recall · March 14, 2018
Bella Capsules recall
Why: Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Bella Capsules, 600mg, 30-count bottles, Manufactured for: Bella All Natural 304 E 11th Street, Los Angeles, CA 90015
- Lots / codes
Lot #: MFD:10.15.2017, Exp.10/14/2019.
- Quantity
- 32 bottles
- Company
- Bella All Natural, Los Angeles, CA
- Distribution
- Product was distributed in California to online customers and retail stores.
- Initiated
- February 14, 2018 · Voluntary: Firm initiated
- Classified
- March 13, 2018
- Reported
- March 14, 2018
- Ended
- January 28, 2019
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.